The immunohistochemical analysis has corroborated the exclusive location of this peptidase in tumor vessels and has shown a higher immunostaining in CCRCC, the most aggressive renal tumor subtype [3] and, specifically, in high grade cases. The gene discussed is LAP3; the disease is kidney neoplasm.